Structural characterization of the PPIase domain of FKBP51, a cochaperone of human Hsp90

被引:56
作者
Bracher, Andreas [1 ]
Kozany, Christian [2 ]
Thost, Ann-Katrin [1 ]
Hausch, Felix [2 ]
机构
[1] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany
[2] Max Planck Inst Psychiat, Chem Genom Res Grp, D-80804 Munich, Germany
来源
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY | 2011年 / 67卷
关键词
isomerases; immunophilin; FK506; drug design; chaperones; PEPTIDYL-PROLYL ISOMERASE; X-RAY STRUCTURES; GLUCOCORTICOID-RECEPTOR; CALCINEURIN INHIBITION; ATOMIC-STRUCTURE; BINDING-PROTEIN; COMPLEXES; FK506; IMMUNOPHILINS; LIGANDS;
D O I
10.1107/S0907444911013862
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Steroid hormone receptors are key components of mammalian stress and sex hormone systems. Many of them rely on the Hsp90 chaperone system for full function and are further fine-tuned by Hsp90-associated peptidyl-prolyl isomerases such as FK506-binding proteins 51 and 52. FK506-binding protein 51 (FKBP51) has been shown to reduce glucocorticoid receptor signalling and has been genetically associated with human stress resilience and with numerous psychiatric disorders. The peptidyl-prolyl isomerase domain of FKBP51 contains a high-affinity binding site for the natural products FK506 and rapamycin and has further been shown to convey most of the inhibitory activity on the glucocorticoid receptor. FKBP51 has therefore become a prime new target for the treatment of stress-related affective disorders that could be amenable to structure-based drug design. Here, a series of high-resolution structures of the peptidyl-prolyl isomerase domain of FKBP51 as well as a cocrystal structure with the prototypic ligand FK506 are described. These structures provide a detailed picture of the drug-binding domain of FKBP51 and the molecular binding mode of its ligand as a starting point for the rational design of improved inhibitors.
引用
收藏
页码:549 / 559
页数:11
相关论文
共 56 条
[1]  
BECKER JW, 1993, J BIOL CHEM, V268, P11335
[2]  
Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI [10.1016/j.psyneuen.2008.08.018, 10.1016/j.psyneuen.2009.05.021]
[3]   Physiological role for the cochaperone FKBP52 in androgen receptor signaling [J].
Cheung-Flynn, J ;
Prapapanich, V ;
Cox, MB ;
Riggs, DL ;
Suarez-Quian, C ;
Smith, DF .
MOLECULAR ENDOCRINOLOGY, 2005, 19 (06) :1654-1666
[4]   Structure of FKBP12.6 in complex with rapamycin [J].
Deivanayagam, CCS ;
Carson, M ;
Thotakura, A ;
Narayana, SVL ;
Chodavarapu, RS .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2000, 56 :266-271
[5]   Structures of immunophilins and their ligand complexes [J].
Dornan, J ;
Taylor, P ;
Walkinshaw, MD .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2003, 3 (12) :1392-1409
[6]   2-aryl-2,2-difluoroacetamide FKBP12 ligands: Synthesis and X-ray structural studies [J].
Dubowchik, GM ;
Vrudhula, VM ;
Dasgupta, B ;
Ditta, J ;
Chen, T ;
Sheriff, S ;
Sipman, K ;
Witmer, M ;
Tredup, J ;
Vyas, DM ;
Verdoorn, TA ;
Bollini, S ;
Vinitsky, A .
ORGANIC LETTERS, 2001, 3 (25) :3987-3990
[7]   Molecular chaperones, essential partners of steroid hormone receptors for activity and mobility [J].
Echeverria, Pablo C. ;
Picard, Didier .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2010, 1803 (06) :641-649
[8]  
Evans P.R., 1997, Protein Crystallogr, V33, P22
[9]   TREATMENT OF NEGATIVE INTENSITY OBSERVATIONS [J].
FRENCH, S ;
WILSON, K .
ACTA CRYSTALLOGRAPHICA SECTION A, 1978, 34 (JUL) :517-525
[10]   Functional drift of sequence attributes in the FK506-binding proteins (FKBPs) [J].
Galat, Andrzej .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2008, 48 (05) :1118-1130